Literature DB >> 24500906

Thinking Outside the Heart: Use of Engineered Cardiac Tissue for the Treatment of Chronic Deep Venous Insufficiency.

Narine Sarvazyan1.   

Abstract

This article considers the use of autologous stem cell-derived cardiomyocytes as a novel means to aid venous return. The approach consists of creating external cuffs of engineered heart tissue around vein segments with incompetent or poorly competent valves. The engineered heart tissue cuff prevents distention of the impaired vein segments and aids unidirectional flow by its rhythmic contractions. There appear to be no fundamental limitations to this approach as feasibility of all of the individual components has already been shown. Here, we underline the clinical need for novel ways to treat chronic deep venous insufficiency, review previous research that enabled this approach, consider potential designs of engineered heart tissue cuffs, and outline its advantages and future challenges.
© The Author(s) 2014.

Entities:  

Keywords:  heart disease; pathophysiology; stem cells therapy; thrombosis

Year:  2014        PMID: 24500906      PMCID: PMC5837029          DOI: 10.1177/1074248413520343

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol Ther        ISSN: 1074-2484            Impact factor:   2.457


  63 in total

1.  Implantation of immature neonatal cardiac cells into the wall of the aorta in rats: a novel model for studying morphological and functional development of heart cells in an extracardiac environment.

Authors:  Wangde Dai; Sharon L Hale; Robert A Kloner
Journal:  Circulation       Date:  2004-07-06       Impact factor: 29.690

2.  Development of a drug screening platform based on engineered heart tissue.

Authors:  Arne Hansen; Alexandra Eder; Marlene Bönstrup; Marianne Flato; Marco Mewe; Sebastian Schaaf; Bülent Aksehirlioglu; Alexander P Schwoerer; Alexander Schwörer; June Uebeler; Thomas Eschenhagen
Journal:  Circ Res       Date:  2010-05-06       Impact factor: 17.367

3.  Transport between blood and peripheral lymph in intestine.

Authors:  A R Hargens; B W Zweifach
Journal:  Microvasc Res       Date:  1976-01       Impact factor: 3.514

4.  Formation of cardiac fibers in Matrigel matrix.

Authors:  Karina Bakunts; Nikki Gillum; Zaruhi Karabekian; Narine Sarvazyan
Journal:  Biotechniques       Date:  2008-03       Impact factor: 1.993

5.  Microfluidic patterning for fabrication of contractile cardiac organoids.

Authors:  Ali Khademhosseini; George Eng; Judy Yeh; Peter A Kucharczyk; Robert Langer; Gordana Vunjak-Novakovic; Milica Radisic
Journal:  Biomed Microdevices       Date:  2007-04       Impact factor: 2.838

6.  Transcommissural valvuloplasty: technique and results.

Authors:  S Raju; M A Berry; P Neglén
Journal:  J Vasc Surg       Date:  2000-11       Impact factor: 4.268

7.  Long-term survival and growth of pulsatile myocardial tissue grafts engineered by the layering of cardiomyocyte sheets.

Authors:  Tatsuya Shimizu; Hidekazu Sekine; Yuki Isoi; Masayuki Yamato; Akihiko Kikuchi; Teruo Okano
Journal:  Tissue Eng       Date:  2006-03

8.  Lower extremity venous anatomy.

Authors:  Mark H Meissner
Journal:  Semin Intervent Radiol       Date:  2005-09       Impact factor: 1.513

9.  Epidemiology of chronic venous disease.

Authors:  L Robertson; C Evans; F G R Fowkes
Journal:  Phlebology       Date:  2008       Impact factor: 1.740

Review 10.  Skeletal myoblasts as a therapeutic agent.

Authors:  Philippe Menasché
Journal:  Prog Cardiovasc Dis       Date:  2007 Jul-Aug       Impact factor: 8.194

View more
  2 in total

Review 1.  Building Valveless Impedance Pumps From Biological Components: Progress and Challenges.

Authors:  Narine Sarvazyan
Journal:  Front Physiol       Date:  2022-01-31       Impact factor: 4.566

2.  Output of a valveless Liebau pump with biologically relevant vessel properties and compression frequencies.

Authors:  Rubina Davtyan; Narine A Sarvazyan
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.